Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, recently achieved a groundbreaking milestone. Led by Director Junwei Pan, the urology team completed the world’s first perineal urethral cancer radical surgery assisted by the innovative SHURUI^® single-port surgical robot. This pioneering procedure opens a new chapter in robotic perineal surgery, offering urethral cancer patients a minimally invasive treatment alternative.

Urethral cancer, a rare malignancy in the urinary system, poses surgical challenges due to complex anatomy and limited operating space. Traditional open surgery often involves large incisions, difficult exposure, and restricted instrument maneuverability, causing greater trauma and longer recovery.

Utilizing the SHURUI^® robot’s flexible snake-arm technology and 10x magnified 3D vision, Director Pan precisely dissected and removed cancerous tissue through a single small incision. This breakthrough not only elevates robotic-assisted urethral cancer treatment but also demonstrates potential applications in breast, ENT, and other traditionally open surgeries.

This achievement highlights China’s leadership in advanced minimally invasive robotic surgery, redefining standards with safer, more efficient, and patient-friendly approaches.